Investors Count

5

Deal Terms

1

Funding, Valuation & Revenue

5 Fundings

Ex Libris's latest funding round was a Acquired for on October 7, 2015.

Ex Libris's latest post-money valuation is from October 2015.

Sign up for a free demo to see Ex Libris's valuations in October 2015 and more.

Date

Round

Amount

Investors

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Revenue

Sources

10/7/2015

Acquired

$XXM

0

FY undefined

1

12/10/2012

Acq - Fin - III

$XXM

$XXM

0

FY undefined

10

8/5/2008

Acq - Fin - II

$XXM

0

FY undefined

10

11/1/2006

Acq - Fin

$XXM

0

FY undefined

10

1/1/1998

Unattributed VC

$XXM

0

FY undefined

10

Date

10/7/2015

12/10/2012

8/5/2008

11/1/2006

1/1/1998

Round

Acquired

Acq - Fin - III

Acq - Fin - II

Acq - Fin

Unattributed VC

Amount

$XXM

Investors

Valuation

$XXM

$XXM

$XXM

$XXM

$XXM

Revenue

0

FY undefined

0

FY undefined

0

FY undefined

0

FY undefined

0

FY undefined

Sources

1

10

10

10

10

Start free trial
New call-to-action

Ex Libris Deal Terms

1 Deal Term

Ex Libris's deal structure is available for 1 funding round, including their Acquired from October 07, 2015.

Round

Acquired

Funding Date

$XXM

Pre-Money Valuation

Post-Money Valuation

$XXM

Amount Raised

Shares Authorized

Issuance Price

Dividend Rate

Liquidation Preferences

Liquidation Price

Participation

Conversion Price

Anti Dilution

General Voting

$XXM

Board Voting

$XXM

Par Value

Round

Funding Date

Pre-Money Valuation

Post-Money Valuation

Amount Raised

Shares Authorized

Issuance Price

Dividend Rate

Liquidation Preferences

Liquidation Price

Participation

Conversion Price

Anti Dilution

General Voting

Board Voting

Par Value

Acquired

$XXM

$XXM

$XXM

$XXM

Ex Libris Investors

5 Investors

Ex Libris has 5 investors. ProQuest invested in Ex Libris's Acquired funding round.

First funding

Last Funding

Investor

Rounds

Board Seats

Type

Location

10/7/2015

10/7/2015

1
Acquired

Corporation

Michigan

00/00/0000

00/00/0000

Golden Gate Capital

Subscribe to see more

Private Equity

California

00/00/0000

00/00/0000

Leeds Equity Partners

Subscribe to see more

Private Equity

New York

00/00/0000

00/00/0000

Francisco Partners

Subscribe to see more

Private Equity

California

00/00/0000

00/00/0000

Walden Israel Venture Capital

Subscribe to see more

Venture Capital

Israel

First funding

10/7/2015

00/00/0000

00/00/0000

00/00/0000

00/00/0000

Last Funding

10/7/2015

00/00/0000

00/00/0000

00/00/0000

00/00/0000

Investor

Golden Gate Capital

Leeds Equity Partners

Francisco Partners

Walden Israel Venture Capital

Rounds

1
Acquired

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Board Seats

Type

Corporation

Private Equity

Private Equity

Private Equity

Venture Capital

Location

Michigan

California

New York

California

Israel

Ex Libris Acquisitions

3 Acquisitions

Ex Libris acquired 3 companies. Their latest acquisition was Innovative Interfaces on December 05, 2019.

Date

Investment Stage

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Total Funding

Note

Sources

12/5/2019

Private Equity

$XXM

Acquired

1

6/20/2019

Subscribe to see more

$XXM

Subscribe to see more

10

8/6/2018

Subscribe to see more

$XXM

Subscribe to see more

10

Date

12/5/2019

6/20/2019

8/6/2018

Investment Stage

Private Equity

Companies

Subscribe to see more

Subscribe to see more

Valuation

$XXM

$XXM

$XXM

Total Funding

Note

Acquired

Subscribe to see more

Subscribe to see more

Sources

1

10

10

New call-to-action

Loading...

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.